| The SLUG zinc-finger protein represses E-cadherin in breast cancer KM Hajra, DYS Chen, ER Fearon Cancer research 62 (6), 1613-1618, 2002 | 1300 | 2002 |
| Aldehyde dehydrogenase in combination with CD133 defines angiogenic ovarian cancer stem cells that portend poor patient survival IA Silva, S Bai, K McLean, K Yang, K Griffith, D Thomas, C Ginestier, ... Cancer research 71 (11), 3991-4001, 2011 | 591 | 2011 |
| Cadherin and catenin alterations in human cancer KM Hajra, ER Fearon Genes, Chromosomes and Cancer 34 (3), 255-268, 2002 | 510 | 2002 |
| Ovarian cancer, version 2.2020, NCCN clinical practice guidelines in oncology DK Armstrong, RD Alvarez, JN Bakkum-Gamez, L Barroilhet, K Behbakht, ... Journal of the National Comprehensive Cancer Network 19 (2), 191-226, 2021 | 467 | 2021 |
| Human ovarian carcinoma–associated mesenchymal stem cells regulate cancer stem cells and tumorigenesis via altered BMP production K McLean, Y Gong, Y Choi, N Deng, K Yang, S Bai, L Cabrera, E Keller, ... The Journal of clinical investigation 121 (8), 3206-3219, 2011 | 394 | 2011 |
| Apoptosome dysfunction in human cancer KM Hajra, JR Liu Apoptosis 9, 691-704, 2004 | 377 | 2004 |
| Cancer SLC43A2 alters T cell methionine metabolism and histone methylation Y Bian, W Li, DM Kremer, P Sajjakulnukit, S Li, J Crespo, ZC Nwosu, ... Nature 585 (7824), 277-282, 2020 | 328 | 2020 |
| γ-Catenin is regulated by the APC tumor suppressor and its oncogenic activity is distinct from that of β-catenin FT Kolligs, B Kolligs, KM Hajra, G Hu, M Tani, KR Cho, ER Fearon Genes & development 14 (11), 1319-1331, 2000 | 281 | 2000 |
| NCCN guidelines insights: Ovarian cancer, version 1.2019: Featured updates to the NCCN guidelines DK Armstrong, RD Alvarez, JN Bakkum-Gamez, L Barroilhet, K Behbakht, ... Journal of the National Comprehensive Cancer Network 17 (8), 896-909, 2019 | 231 | 2019 |
| Association between life purpose and mortality among US adults older than 50 years A Alimujiang, A Wiensch, J Boss, NL Fleischer, AM Mondul, K McLean, ... JAMA network open 2 (5), e194270-e194270, 2019 | 204 | 2019 |
| The flipped classroom for medical students H Morgan, K McLean, C Chapman, J Fitzgerald, A Yousuf, M Hammoud The clinical teacher 12 (3), 155-160, 2015 | 196 | 2015 |
| E-cadherin is a WT1 target gene S Hosono, I Gross, MA English, KM Hajra, ER Fearon, JD Licht Journal of Biological Chemistry 275 (15), 10943-10953, 2000 | 167 | 2000 |
| NCCN guidelines® insights: Ovarian cancer, version 3.2022: Featured updates to the NCCN guidelines DK Armstrong, RD Alvarez, FJ Backes, JN Bakkum-Gamez, L Barroilhet, ... Journal of the National Comprehensive Cancer Network 20 (9), 972-980, 2022 | 137 | 2022 |
| Human carcinoma-associated mesenchymal stem cells promote ovarian cancer chemotherapy resistance via a BMP4/HH signaling loop LG Coffman, YJ Choi, K McLean, BL Allen, MP di Magliano, ... Oncotarget 7 (6), 6916, 2016 | 136 | 2016 |
| Extinction of E-cadherin expression in breast cancer via a dominant repression pathway acting on proximal promoter elements KM Hajra, X Ji, ER Fearon Oncogene 18 (51), 7274-7279, 1999 | 135 | 1999 |
| Phase II clinical trial of metformin as a cancer stem cell–targeting agent in ovarian cancer JR Brown, DK Chan, JJ Shank, KA Griffith, H Fan, R Szulawski, K Yang, ... JCI insight 5 (11), 2020 | 134 | 2020 |
| CD24+ Ovarian Cancer Cells Are Enriched for Cancer-Initiating Cells and Dependent on JAK2 Signaling for Growth and Metastasis D Burgos-Ojeda, R Wu, K McLean, YC Chen, M Talpaz, E Yoon, KR Cho, ... Molecular cancer therapeutics 14 (7), 1717-1727, 2015 | 93 | 2015 |
| Personalized medicine–based approach to model patterns of chemoresistance and tumor recurrence using ovarian cancer stem cell spheroids S Raghavan, P Mehta, MR Ward, ME Bregenzer, EMA Fleck, L Tan, ... Clinical Cancer Research 23 (22), 6934-6945, 2017 | 91 | 2017 |
| Identifying alemtuzumab as an anti-myeloid cell antiangiogenic therapy for the treatment of ovarian cancer HL Pulaski, G Spahlinger, IA Silva, K McLean, AS Kueck, RK Reynolds, ... Journal of translational medicine 7, 1-14, 2009 | 80 | 2009 |
| Leukemia inhibitory factor functions in parallel with interleukin-6 to promote ovarian cancer growth K McLean, L Tan, DE Bolland, LG Coffman, LF Peterson, M Talpaz, ... Oncogene 38 (9), 1576-1584, 2019 | 73 | 2019 |
